IL2 and neoplasm: In contrast, in an iPSC-derived NK cell therapy, best anti-tumor response was obtained when a total of 3 doses of NK cells were administrated together with 5 doses of IL-2 cytokine injections into pre-irradiated mice bearing OvCa tumors [8].